OXCT1 and gastric cancer: Liu et al. found that circ-OXCT1 overexpression inhibited gastric cancer EMT progress by competitively sponging miR-136, which implied that manipulating circ-OXCT1 levels could be a novel treatment for advanced gastric cancer [85].